Intera Atlas
Run match
Sites / Revival Research Institute
Is this you?

Request access for Revival Research Institute with your @revivalresearch.org work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Revival Research Institute

Unclaimed profile

Site Network · Southfield, Michigan · ~10+ sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 8Lift (cardio sample) 0.30Recruit soph 0.14
Quality Scorecard (1–100)
Overall61Recruit59Ops60Sponsor66Ther61

Performance (observed)

Historical trials
168
Completed
78
Terminated/Withdrawn
16
Completion rate
83%
Active now
72
Phase 2
65
Phase 3
91
Realized enrollment
263,242
First study year
2016
Years active
10
Match confidence
high
Enrollment velocity (inf)
26,324

Therapeutic

Areas
Dermatology, Internal Medicine, Cardiology, Psychiatry, Pulmonology, Rheumatology, Women's Health, Oncology, Endocrinology
Breadth (conditions)
146
States
MI, TX, IL, NC, GA, NE, NJ, Poland

Recruitment (web observed)

Advertises recruitment
Yes
Capability notes
Strategic, targeted recruitment strategies with multiple patient engagement channels; publicly emphasizes 'Highest Patient Recruitment' capabilities

Relationships

Sponsors
Eli Lilly and Company; Pfizer; AbbVie; Incyte Corporation; Janssen Research & Development, LLC; Amgen
CROs
Ergomed PLC; ICON Clinical Research; IQVIA Biotech; Medpace, Inc.; PPD Development, LP
Owner / parent
Founder-led (Mazhar Jaffry); established 2015; privately held; 63 employees growing +17.6% YoY

Capacity & people

Investigators
—
Coordinators
—
CEO
Mazhar Jaffry (Founder & CEO)
VP Clinical Ops
Ravi Alla (Director of Clinical Administration)
VP Site Ops
Sikar Grewal (Director of Clinical Research)
VP Recruitment
Nicole Stiff (Corporate Operations & Business Development Manager)
Emails
info@rev-research.com

Tech & DCT

Builds tech
Vendors (RealTime-CTMS partnership; demonstrates platform integration mindset)
Tech stack
RealTime-CTMS partnership; modern, tech-enabled operating model; awarded SCRS 2024 'Bright Idea — Site Tech Enablement Award'
Recruiting visible
Y

Notes

Strong Intera fit: Multi-state network with 10+ sites, broad therapeutic areas, founder-led growth trajectory (+17.6% YoY), tech-forward (SCRS tech award), publicly advertises patient recruitment, rapid startup and enrollment focus. Weakness: No explicit mention of AI or DCT capabilities. Ideal customer profile match: nimble mid-size founder-led platform targeting enrollment acceleration. [Validated: 6 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 0.35Liftability 0.30Overall61

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.